123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases.

123I-Interleukin-2: biochemical characterization and in vivo use for imaging autoimmune diseases.

We describe in detail the labelling of interleukin-2 with I ( I-IL2), its biochemical characterization, the binding assay and its use for the detection of tissues infiltrated with mononuclear cells. Human recombinant IL2 was labelled using an enzymatic method and its biochemical characterization was...

Full description

Bibliographic Details
Main Authors:	Signore, A, Picarelli, A, Annovazzi, A, Britton, K, Grossman, AB, Bonanno, E, Maras, B, Barra, D, Pozzilli, P
Format:	Journal article
Language:	English
Published:	2003

Similar Items

Labelling of interleukin 2 with 123 iodine and its administration to animals susceptible to diabetes for the visualization of lymphocytic infiltration in the pancreas
by: Signore, A, et al.
Published: (1988)

[Labelling of interleukin 2 with 123 iodine and its administration to animals susceptible to diabetes for the visualization of lymphocytic infiltration in the pancreas]
by: Signore, A, et al.
Published: (1988)

I-123-labelled interleukin-12, a new radiopharmaceutical for imaging Th1-mediated chronic inflammation: In vitro and animal studies
by: Annovazzi, A, et al.
Published: (2003)

Labelling of interleukin-2 (IL-2) with 123-iodine with retention of its capacity to bind to activated lymphocytes.
by: Signore, A, et al.
Published: (1987)

Detection of activated lymphocytes in endocrine pancreas of BB/W rats by injection of 123I-interleukin-2: an early sign of type 1 diabetes.
by: Signore, A, et al.
Published: (1987)

In vivo labelling of activated T lymphocytes by i.v. injection of 123I-IL2 for detection of insulitis in type 1 diabetes.
by: Signore, A, et al.
Published: (1990)

99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study.
by: Chianelli, M, et al.
Published: (2008)

Synthesis of Tc-99m-Hynic-interleukin-12, a new radiopharmaceutical for imaging Th-1-lymphocytes
by: Annovazzi, A, et al.
Published: (2004)

Synthesis of 99mTc-HYNIC-interleukin-12, a new specific radiopharmaceutical for imaging T lymphocytes.
by: Annovazzi, A, et al.
Published: (2006)

Ocular metastases secondary to carcinoid tumors: the utility of imaging with [(123)I]meta-iodobenzylguanidine and [(111)In]DTPA pentetreotide.
by: Isidori, A, et al.
Published: (2002)

Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
by: Ur, E, et al.
Published: (1993)

The role of 123I-diagnostic imaging in the follow-up of patients with differentiated thyroid carcinoma as compared to 131I-scanning: avoidance of negative therapeutic uptake due to stunning.
by: Siddiqi, A, et al.
Published: (2001)

Carcinoid tumours presenting as breast cancer: the utility of radionuclide imaging with 123I-MIBG and 111In-DTPA pentetreotide.
by: Kaltsas, G, et al.
Published: (1998)

I-123 imaging for the prediction of I-131 therapy for recurrent differentiated thyroid cancer, RDTC, when I-131 tracer is negative but raised thyroglobulin, Tg
by: Britton, K, et al.
Published: (1999)

The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy.
by: Ali, N, et al.
Published: (2006)

Autoimmune Neuroinflammatory Diseases: Role of Interleukins
by: Abdul Waheed Khan, et al.
Published: (2023-04-01)

Latent Autoimmune Diabetes in Adults: Current Status and New Horizons
by: Paolo Pozzilli, et al.
Published: (2018-06-01)

FEATURES OF INTERLEUKIN-2 AND INTERLEUKIN-4 PRODUCTION AND RECEPTION IN AUTOIMMUNE THYROID DISORDERS
by: T. V. Saprina
Published: (2014-07-01)

Interleukin-35 in autoimmune dermatoses: Current concepts
by: Xie Yuming, et al.
Published: (2022-03-01)

Role of Interleukin-37 in Inflammatory and Autoimmune Diseases
by: Xiaoying Wang, et al.
Published: (2018-09-01)

A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analog (Tyr-3-octreotide) in metastatic carcinoid tumors.
by: Bomanji, J, et al.
Published: (1992)

Stress and the single cytokine: interleukin modulation of the pituitary-adrenal axis.
by: Busbridge, N, et al.
Published: (1991)

Synthesis and characterization of Ln-123 superconductors
by: ARTURAS ZALGA, et al.
Published: (2008-04-01)

Synthesis and characterization of Ln-123 superconductors
by: Zalga Arturas, et al.
Published: (2008-01-01)

Interleukin-1 beta and interleukin-6 stimulate neurohypophysial hormone release in vitro.
by: Yasin, SA, et al.
Published: (1994)

P123
by: E. Matiunina, et al.
Published: (2015-11-01)

Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.
by: Li Zhao, et al.
Published: (2011-04-01)

Multimodality palliative treatment of (111)In-pentetreotide negative/(123)I-MIBG positive metastatic carcinoid - a case report.
by: Dworakowska, D, et al.
Published: (2008)

Interleukin-18 Binding Protein in Immune Regulation and Autoimmune Diseases
by: Seung Yong Park, et al.
Published: (2022-07-01)

Interleukin-23 Involved in Fibrotic Autoimmune Diseases: New Discoveries
by: Margherita Sisto, et al.
Published: (2023-09-01)

Interleukin 35-Producing Exosomes Suppress Neuroinflammation and Autoimmune Uveitis
by: Minkyung Kang, et al.
Published: (2020-05-01)

123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation.
by: Bhatia, K, et al.
Published: (2008)

The interleukin-1 receptor antagonist gene shows no allelic association with three autoimmune diseases.
by: Heward, J, et al.
Published: (1999)

The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice.
by: Signore, A, et al.
Published: (1989)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
by: Cornelissen, B, et al.
Published: (2004)

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
by: Powrie, F, et al.
Published: (1993)

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
by: Powrie, F, et al.
Published: (1993)

In vivo imaging in autoimmune diseases in the central nervous system
by: Naoto Kawakami
Published: (2016-07-01)

Multifunctional Interleukin-24 Resolves Neuroretina Autoimmunity via Diverse Mechanisms
by: Xuan Zhang, et al.
Published: (2022-10-01)

Interleukin-22, a potent target for treatment of non-autoimmune diseases
by: Yue Zheng, et al.
Published: (2018-12-01)